Literature DB >> 24368468

Changes in testing for human immunodeficiency virus, sexually transmitted infections, and hepatitis C virus in opioid treatment programs.

Marcus A Bachhuber1, Chinazo O Cunningham1.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24368468      PMCID： PMC4038104          DOI： 10.1001/jama.2013.278456

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  3 in total

1.  HIV testing and counseling in the nation's outpatient substance abuse treatment system, 1995-2005.

Authors:  Harold A Pollack; Thomas D'Aunno
Journal:  J Subst Abuse Treat       Date:  2010-02-19

2.  Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings.

Authors:  Bernard M Branson; H Hunter Handsfield; Margaret A Lampe; Robert S Janssen; Allan W Taylor; Sheryl B Lyss; Jill E Clark
Journal:  MMWR Recomm Rep       Date:  2006-09-22

3.  Implementing rapid HIV testing with or without risk-reduction counseling in drug treatment centers: results of a randomized trial.

Authors:  Lisa R Metsch; Daniel J Feaster; Lauren Gooden; Tim Matheson; Raul N Mandler; Louise Haynes; Susan Tross; Tiffany Kyle; Dianne Gallup; Andrzej S Kosinski; Antoine Douaihy; Bruce R Schackman; Moupali Das; Robert Lindblad; Sarah Erickson; P Todd Korthuis; Steve Martino; James L Sorensen; José Szapocznik; Rochelle Walensky; Bernard Branson; Grant N Colfax
Journal:  Am J Public Health       Date:  2012-04-19       Impact factor: 9.308
  3 in total
  8 in total

Review 1.  Colocalization in Hepatitis C Virus Infection Care: The Role of Opioid Agonist Therapy Clinics.

Authors:  Lynn E Taylor
Journal:  Clin Liver Dis (Hoboken)       Date:  2020-07-21

2.  Medicaid Coverage of Methadone Maintenance and the Use of Opioid Agonist Therapy Among Pregnant Women in Specialty Treatment.

Authors:  Marcus A Bachhuber; Pooja K Mehta; Laura J Faherty; Brendan Saloner
Journal:  Med Care       Date:  2017-12       Impact factor: 2.983

3.  Viral hepatitis among drug users in methadone maintenance: associated factors, vaccination outcomes, and interventions.

Authors:  David C Perlman; Ashly E Jordan; Courtney McKnight; Christopher Young; Kevin L Delucchi; James L Sorensen; Don C Des Jarlais; Carmen L Masson
Journal:  J Addict Dis       Date:  2014

Review 4.  Synthetic Opioid Use and Common Injection-associated Viruses: Expanding the Translational Research Agenda.

Authors:  Jason T Blackard; Jennifer L Brown; Michael S Lyons
Journal:  Curr HIV Res       Date:  2019       Impact factor: 1.581

5.  HIV and Hepatitis C Virus Testing and Treatment Services in Specialty Treatment Facilities That Offer Medication for Opioid Use Disorder in the US.

Authors:  Eshan U Patel; Becky L Genberg; Xianming Zhu; Noa Krawczyk; Shruti H Mehta; Aaron A R Tobian
Journal:  JAMA       Date:  2022-02-22       Impact factor: 157.335

Review 6.  Treatment of Chronic Hepatitis C in Patients Receiving Opioid Agonist Therapy: A Review of Best Practice.

Authors:  Brianna L Norton; Matthew J Akiyama; Philippe J Zamor; Alain H Litwin
Journal:  Infect Dis Clin North Am       Date:  2018-06       Impact factor: 5.982

Review 7.  Opioid epidemic and liver disease.

Authors:  Elizabeth C Verna; Aaron Schluger; Robert S Brown
Journal:  JHEP Rep       Date:  2019-07-09

8.  Quick diagnosis, staging, and treatment of HCV infection among people living in prison: Opinion expert panel.

Authors:  Vito Fiore; Giuseppe De Matteis; Emanuele Pontali; Andrea De Vito; Sandro Panese; Nicholas Geremia; Ivana Maida; Stefania Artioli; Giulio Starnini; Giordano Madeddu; Sergio Babudieri
Journal:  Front Public Health       Date:  2022-10-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.